A double-blind, placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease in Argentina. Design, organization and general characteristics of patients at entry. The EMATAP Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples